Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_1
2
50%
Ph not_applicable
2
50%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting2
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (50.0%)
N/A2 (50.0%)

Trials by Status

active_not_recruiting250%
completed125%
unknown125%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruitingnot_applicable

BCG Revaccination Study in Diabetic and Non-Diabetic Adults

NCT06246851
active_not_recruitingnot_applicable

ID93/GLA-SE Vaccination + BCG Challenge

NCT06670755
completedphase_1

Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers

NCT04777721
unknownphase_1

Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults

NCT03912207

Clinical Trials (4)

Showing 4 of 4 trials
NCT06246851Not Applicable

BCG Revaccination Study in Diabetic and Non-Diabetic Adults

Active Not Recruiting
NCT06670755Not Applicable

ID93/GLA-SE Vaccination + BCG Challenge

Active Not Recruiting
NCT04777721Phase 1

Aerosol BCG Challenge Study in Historically BCG-vaccinated Volunteers

Completed
NCT03912207Phase 1

Investigating Immune Responses to Aerosol BCG Challenge in Healthy UK Adults

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4